Literature DB >> 32350078

Parenteral lipids shape gut bile acid pools and microbiota profiles in the prevention of cholestasis in preterm pigs.

Lee Call1, Tiffany Molina2, Barbara Stoll1, Greg Guthrie1, Shaji Chacko1, Jogchum Plat3, Jason Robinson1, Sen Lin4, Caitlin Vonderohe1, Mahmoud Mohammad1, Dennis Kunichoff1, Stephanie Cruz5, Patricio Lau5, Muralidhar Premkumar2, Jon Nielsen6, Zhengfeng Fang4, Oluyinka Olutoye5, Thomas Thymann6, Robert Britton7, Per Sangild6, Douglas Burrin8.   

Abstract

Multi-component lipid emulsions, rather than soy-oil emulsions, prevent cholestasis by an unknown mechanism. Here, we quantified liver function, bile acid pools, and gut microbial and metabolite profiles in premature parenterally fed pigs given a soy-oil lipid emulsion, Intralipid (IL), a multi component lipid emulsion, SMOFlipid (SMOF), a novel emulsion with a modified fatty-acid composition [experimental emulsion (EXP)], or a control enteral diet (ENT) for 22 days. We assayed serum cholestasis markers, measured total bile acid levels in plasma, liver, and gut contents, and analyzed colonic bacterial 16S rRNA gene sequences and metabolomic profiles. Serum cholestasis markers (i.e., bilirubin, bile acids, and γ-glutamyl transferase) were highest in IL-fed pigs and normalized in those given SMOF, EXP, or ENT. Gut bile acid pools were lowest in the IL treatment and were increased in the SMOF and EXP treatments and comparable to ENT. Multiple bile acids, especially their conjugated forms, were higher in the colon contents of SMOF and EXP than in IL pigs. The colonic microbial communities of SMOF and EXP pigs had lower relative abundance of several gram-positive anaerobes, including Clostridrium XIVa, and higher abundance of Enterobacteriaceae than those of IL and ENT pigs. Differences in lipid and microbial-derived compounds were also observed in colon metabolite profiles. These results indicate that multi-component lipid emulsions prevent cholestasis and restore enterohepatic bile flow in association with gut microbial and metabolomic changes. We conclude that sustained bile flow induced by multi-component lipid emulsions likely exerts a dominant effect in reducing bile acid-sensitive gram-positive bacteria.

Entities:  

Keywords:  Enterobacteriaceae; cholestasis; clostridium; fatty acids; liver; metabolomics; microbiome; parenteral nutrition; sterols

Mesh:

Substances:

Year:  2020        PMID: 32350078      PMCID: PMC7328048          DOI: 10.1194/jlr.RA120000652

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  59 in total

1.  Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform.

Authors:  James J Kozich; Sarah L Westcott; Nielson T Baxter; Sarah K Highlander; Patrick D Schloss
Journal:  Appl Environ Microbiol       Date:  2013-06-21       Impact factor: 4.792

2.  Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.

Authors:  Kathleen M Gura; Christopher P Duggan; Sharon B Collier; Russell W Jennings; Judah Folkman; Bruce R Bistrian; Mark Puder
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

3.  ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Lipids.

Authors:  Alexandre Lapillonne; Nataša Fidler Mis; Olivier Goulet; Chris H P van den Akker; Jennifer Wu; Berthold Koletzko
Journal:  Clin Nutr       Date:  2018-06-18       Impact factor: 7.324

Review 4.  Practice of parenteral nutrition in VLBW and ELBW infants.

Authors:  Nicholas D Embleton; Karen Simmer
Journal:  World Rev Nutr Diet       Date:  2014-04-11       Impact factor: 0.575

5.  Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.

Authors:  Takeshi Inagaki; Mihwa Choi; Antonio Moschetta; Li Peng; Carolyn L Cummins; Jeffrey G McDonald; Guizhen Luo; Stacey A Jones; Bryan Goodwin; James A Richardson; Robert D Gerard; Joyce J Repa; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell Metab       Date:  2005-10       Impact factor: 27.287

6.  Serum plant sterols, cholestanol, and cholesterol precursors associate with histological liver injury in pediatric onset intestinal failure.

Authors:  Annika Mutanen; Markku J Nissinen; Jouko Lohi; Päivi Heikkilä; Helena Gylling; Mikko P Pakarinen
Journal:  Am J Clin Nutr       Date:  2014-08-06       Impact factor: 7.045

Review 7.  Immune modulation by parenteral lipid emulsions.

Authors:  Geert J A Wanten; Philip C Calder
Journal:  Am J Clin Nutr       Date:  2007-05       Impact factor: 7.045

8.  Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR.

Authors:  Beth A Carter; Olga A Taylor; Daniel R Prendergast; Tracy L Zimmerman; Richard Von Furstenberg; David D Moore; Saul J Karpen
Journal:  Pediatr Res       Date:  2007-09       Impact factor: 3.756

9.  Distinct Plasma Bile Acid Profiles of Biliary Atresia and Neonatal Hepatitis Syndrome.

Authors:  Kejun Zhou; Jun Wang; Guoxiang Xie; Ying Zhou; Weihui Yan; Weihua Pan; Yanran Che; Ting Zhang; Linda Wong; Sandi Kwee; Yongtao Xiao; Jie Wen; Wei Cai; Wei Jia
Journal:  J Proteome Res       Date:  2015-10-16       Impact factor: 4.466

Review 10.  ESPGHAN Committee on Nutrition Position Paper. Intravenous Lipid Emulsions and Risk of Hepatotoxicity in Infants and Children: a Systematic Review and Meta-analysis.

Authors:  Iva Hojsak; Virginie Colomb; Christian Braegger; Jiri Bronsky; Cristina Campoy; Magnus Domellöf; Nicholas Embleton; Nataša Fidler Mis; Jessie M Hulst; Flavia Indrio; Alexandre Lapillonne; Walter Mihatsch; Christian Molgaard; Johannes van Goudoever; Mary Fewtrell
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-05       Impact factor: 2.839

View more
  6 in total

1.  Tissue-specific mechanisms of bile acid homeostasis and activation of FXR-FGF19 signaling in preterm and term neonatal pigs.

Authors:  Caitlin Vonderohe; Greg Guthrie; Barbara Stoll; Shaji Chacko; Harry Dawson; Douglas G Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-12-01       Impact factor: 4.052

Review 2.  Fibroblast growth factor 15/19 expression, regulation, and function: An overview.

Authors:  Greg Guthrie; Caitlin Vonderohe; Douglas Burrin
Journal:  Mol Cell Endocrinol       Date:  2022-03-15       Impact factor: 4.369

3.  Depletion and enrichment of phytosterols in soybean oil lipid emulsions directly associate with serum markers of cholestasis in preterm parenteral nutrition-fed pigs.

Authors:  Greg Guthrie; Barbara Stoll; Shaji Chacko; Mahmoud Mohammad; Candace Style; Mariatu Verla; Oluyinka Olutoye; Deborah Schady; Charlotte Lauridsen; Nick Tataryn; Douglas Burrin
Journal:  JPEN J Parenter Enteral Nutr       Date:  2021-04-30       Impact factor: 4.016

4.  New Insights and Enhanced Human Norovirus Cultivation in Human Intestinal Enteroids.

Authors:  Khalil Ettayebi; Victoria R Tenge; Nicolas W Cortes-Penfield; Sue E Crawford; Frederick H Neill; Xi-Lei Zeng; Xiaomin Yu; B Vijayalakshmi Ayyar; Douglas Burrin; Sasirekha Ramani; Robert L Atmar; Mary K Estes
Journal:  mSphere       Date:  2021-01-27       Impact factor: 4.389

Review 5.  Impact of Parenteral Lipid Emulsion Components on Cholestatic Liver Disease in Neonates.

Authors:  Gregory Guthrie; Douglas Burrin
Journal:  Nutrients       Date:  2021-02-04       Impact factor: 5.717

6.  Ursodeoxycholic Acid and SMOFlipid for Treating Parenteral Nutrition Associated Cholestasis in Infants.

Authors:  Saleh Al-Alaiyan; Weam Elsaidawi; Amal M Alanazi; Raef A Qeretli; Najlaa A Abdulaziz; Areej Alfattani
Journal:  Cureus       Date:  2022-02-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.